Ryan Kwan is a corporate, M&A and securities lawyer based in Hong Kong. He has extensive experience in Hong Kong equity capital markets, including initial public offerings, corporate transactions by companies listed on the Hong Kong Stock Exchange, and regulatory matters related to the Listing Rules of the Hong Kong Stock Exchange and Takeovers Code.
Representative experience
IPO
-
Dtech (1377.HK): H-share Main Board IPO and HK$4.8 billion global offering by A-share listed company. Represented CITICS and HSBC.
-
Qiyunshan Food (2797.HK): H-share Main Board IPO and HK$200 million global offering. Represented the Company.
-
DOBOT (2432.HK): H-share 18C Main Board IPO and HK$750 million global offering. Represented Guotai Junan and ABCI.
-
Soft International (2569.HK): Main Board IPO and HK$130 million global offering. Represented Sunny Fortune Capital.
-
UBTECH (9880.HK): H-share Main Board IPO and HK$1.02 billion global offering. Served as the Company's special legal counsel.
-
Rego Interactive (2422.HK): Main Board IPO and HK$160 million global offering. Represented CMBC International.
-
Huzhou Gas (6661.HK): H-share Main Board IPO and HK$300 million global offering. Represented the Company.
-
Jiaxing Gas (9908.HK): H-share Main Board IPO and HK$330 million global offering. Represented the Company.
-
Activation (9919.HK): Main Board IPO and HK$400 million global offering. Represented the Company.
-
JPJ (TCM): proposed spin-off listing. A1 application filed. Represented the Company.
-
Nova Insight: proposed Main Board IPO. A1 application filed. Represented JPM and HSBC.
-
Capital Securities: proposed H-share Main Board IPO by A-share listed company. A1 application filed. Represented the Company.
-
Cheng-Tech: proposed H-share Main Board IPO. A1 application filed. Represented Guotai Junan.
-
Beijing Tiandi Hexing Technology: proposed H-share Main Board IPO. A1 application filed. Represented China Securities International and Orient Securities International.
-
Changzhou Microintelligence: proposed H-share Main Board IPO. A1 application filed. Represented Orient Securities International.
-
Gemilai: proposed Main Board IPO. A1 application filed. Represented the Company.
-
A Wuhan-based biopharmaceutical company: proposed H-share Main Board IPO by A-share listed company. Represented the Company.
-
A Shenzhen-based nanotechnology materials company: proposed H-share 18C main board IPO. Represented the Sponsors.
Annual retainer
-
UBTECH (9880.HK)
-
DOBOT (2432.HK)
-
Activation (9919.HK)
-
Huzhou Gas (6661.HK)
-
AUX International (2080.HK)
-
Yichen Industrial (1596.HK)
-
Pak Tak International (2668.HK)
-
SCE Intelligent Commercial Management (606.HK)
-
Stella International Holdings (1836.HK)
-
China All Access (delisted in 2023)
Placing
-
Dalipal Holdings (1921.HK): HK$392 million top-up placing of 74,250,000 shares. Represented the Company.
-
UBTECH (9880.HK): HK$2.07 billion placing of new shares.
-
DOBOT (2432.HK):HK$1.04 billion placing of new shares.
-
Pak Tak International (2668.HK): Placing of a total of HK$200 million of new shares to unspecified placees and designated investor.
Other relevant experience
-
UBTECH (9880.HK): various transactions including investment and financing of subsidiaries, disclosable and continuing connected transactions, and full circulation of H shares.
-
Yichen Industrial (1596.HK): proposed A share listing on the Shenzhen Stock Exchange.
-
SCE Intelligent Commercial Management (606.HK): major and connected transaction involving the provision of RMB900 million loan to a connected person.
-
AUX International (2080.HK): continuing connected transaction involving the provision of property management services of approximately RMB300 million to connected persons.
-
China All Access (delisted, 633.HK prior to delisting): capital injection of RMB300 million in subsidiary constituting deemed very substantial disposal transaction.
Admissions
- Solicitor, qualified in Hong Kong
Languages
- English
- Mandarin Chinese
- Cantonese